Universal (UVV) Earnings Date & Reports

Key Takeaways

• Universal Corporation reported second quarter fiscal 2027 revenue of $621.8 million, down 18% from $754.2 million a year earlier and below the consensus estimate of about $630.1 million.
• Diluted earnings per share (EPS) came in at $0.50, down 63% from $1.36 in the prior-year quarter and short of the $0.58 analysts expected.
• Adjusted (non-GAAP) diluted EPS was $0.39, reflecting lower tobacco shipment volumes tied to what management called a delayed oversupply cycle.
• Gross margin narrowed to 17.3% from 18.5%, highlighting ongoing cost pressures across the business.
• Total debt rose to about $1.20 billion, while the company maintained roughly $945 million of available liquidity.
• For more detail, explore Universal Corporation's Major News, Today's Price Move, Price Targets, and Forecast pages.
• You can also explore Trending AI Robots to discover AI-driven trading strategies and signals.

Earnings Context and Why It Matters

Universal Corporation is a global leaf tobacco supplier and agriproducts company with operations in more than 30 countries, and its fiscal year runs from April through March. The second quarter of fiscal 2027, which ended September 30, 2026, is a pivotal checkpoint because the business is highly seasonal. Green tobacco buying, customer commitments, and shipping schedules from regions such as Africa and Brazil heavily influence quarterly results. The company entered the quarter navigating a delayed oversupply cycle in tobacco, which had already weighed on its fiscal first quarter, when revenue and EPS missed expectations. For investors, this report offers a read on whether shipment timing is normalizing and whether the company's Ingredients segment can begin recovering from fixed-cost and demand headwinds.

Reported Results

Universal Corporation reported second quarter fiscal 2027 revenue of $621.8 million, an 18% decline from $754.2 million in the same period last year and below the roughly $630.1 million analysts had anticipated. Diluted EPS was $0.50, down 63% from $1.36 a year earlier and below the consensus estimate of $0.58. On an adjusted, non-GAAP basis (a measure that excludes certain one-time items), diluted EPS was $0.39.

Net income attributable to Universal Corporation fell to approximately $12.6 million, while adjusted operating income declined 41% to about $39.9 million. Gross profit margin narrowed to 17.3% from 18.5%. For the first half of fiscal 2027, consolidated revenue fell 15% to about $1.1 billion, driven by an 18% decline in tobacco sales volumes, and the Ingredients segment posted an operating loss of $2.7 million versus income of $1.5 million a year earlier.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening. For investors following names like Universal Corporation, it offers a practical way to surface comparable setups and monitor shifting momentum across sectors.

Market Reaction and Investor Sentiment

Because Universal Corporation released its results after the market close on November 4, 2026, the full market reaction is still developing as investors digest the figures in subsequent sessions. The quarter's top- and bottom-line misses, combined with a sharp year-over-year EPS decline, reinforce the narrative that fiscal 2027 is unfolding as a timing-driven year. Management emphasized that the shortfall reflects the slower shipment cadence of a delayed oversupply cycle rather than a fundamental change in demand, and that customer commitments remain in line with full-year sales plans. Investor sentiment heading forward will likely hinge on whether second-half shipment volumes recover as projected and whether the Ingredients segment's restructuring efforts begin to show measurable progress.

Forward Outlook and Key Factors to Monitor

Universal Corporation enters the back half of fiscal 2027 with management pointing to a second-half-weighted shipment schedule. The company said customer commitments align with its full-year sales plans, and uncommitted tobacco inventories stood at 19%, within its target range. If shipping instructions from Africa and Brazil continue to normalize, the Tobacco Operations segment could recover some of the ground lost in the first half.

Investors should watch tobacco shipment volumes and the pace of green tobacco buying, since these drive the company's highly seasonal revenue. The broader oversupply environment in flue-cured, burley, and dark air-cured tobacco remains a key variable, as it can pressure both volumes and pricing.

On the Ingredients side, management is restructuring the platform into a more integrated organization, a process it expects to continue through the next fiscal year. Progress here matters because the segment has faced weak consumer-packaged-goods demand, tight Pacific Northwest apple supplies, raw material constraints, and inflationary cost pressures.

Finally, balance sheet discipline will stay in focus. With total debt near $1.20 billion and roughly $945 million of available liquidity, the company's ability to fund seasonal working capital while managing leverage will be closely watched as shipments accelerate later in the fiscal year.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations